Labcyte

BLOG

TUESDAY, JANUARY 16, 2018

The New Sound of Sample Management

When AstraZeneca wanted to update its pharmaceutical compound management with a fully acoustic system, we were happy to take on the challenge. Two years later, we are happy to be able to offer the amazing automated workflow solution to all of our customers, as part of the new Access™ Dual Robot System (DRS) - to be revealed at SLAS2018.

Read More

THURSDAY, NOVEMBER 30, 2017

Precision at the Heart of Precision Oncology

The future of precision oncology is happening now, in the labs of Seattle-based start-up SEngine, where individual patient tumor cells are screened against a library of nearly 150 drugs to find the optimal personalized treatment.

Read More

FRIDAY, NOVEMBER 10, 2017

Hopping Over the Hype of Precision Medicine

If we want to win the race against cancer, we cannot rely solely on genomics-based testing, argues Senior Research Fellow Joe Olechno in an article that appeared in Medicine Maker.

Read More

WEDNESDAY, NOVEMBER 08, 2017

FIMM Extends Personalized Medicine Collaboration with Labcyte

It’s brought unparalleled levels of precision to precision medicine, and enabled cancer treatment to be truly tailored to individual patients. Now Labcyte’s acoustic liquid handling technology will help the Institute for Molecular Medicine Finland (FIMM) take its innovative functional cell screening strategies to the next level.

Read More

MONDAY, NOVEMBER 06, 2017

Interlaboratory Reproducibility of ddPCR Using a New DNA Reference Material Format

Whether it be pathogen detection, biomarker quantification or genome editing, polymerase chain reaction (PCR) technology is being used across a multitude of the life sciences, due to its unprecedented levels of precision, accuracy and resolution. There is great interest in moving the latest iteration of this technology — droplet digital PCR (ddPCR) — from research labs to clinical settings, but it will require processes for method validation, verification and reproducibility.

Read More

THURSDAY, OCTOBER 26, 2017

Get to Know the People at Labcyte!

We have launched a new section on our website dedicated to profiling our company’s greatest asset – our people. We will continue to add new profiles on a regular basis, and to feature employees from a range of departments. We’re asking them about their jobs, what excites them about their work, career advice, what they do outside of the office, and more. This is a great way to learn more about your sales manager, customer service rep or application scientist, and the many other people who make Labcyte tick.

Read More

MONDAY, OCTOBER 23, 2017

Customer Spotlight: SEngine Precision Medicine

The complex analysis of multiple data types is greatly needed in precision medicine, according to Fred Hutchinson Cancer Research Center scientist Carla Grandori. She’s striving to meet that need via SEngine, a Seattle-based enterprise that harnesses the power of genomics and robotics to create truly tailored treatment assessments for those with cancer.

Read More

THURSDAY, SEPTEMBER 14, 2017

Nature Medicine Perspective Piece on Functional Precision Cancer Medicine

In a recent Perspective piece in Nature Medicine, Dana Farber cancer researcher Tony Letai, M.D., Ph.D., makes a compelling case for focusing more attention and resources on the functional application of precision medicine, rather than pure genomics.

Read More